Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
KP Rx is a founder-owned investment firm established in 2023 and based in Sydney, Australia. The firm focuses on private and early-stage public healthcare investments, specifically in Australia and New Zealand. KP Rx targets high-potential companies in the biotech, medical devices, diagnostics, and health tech sectors, particularly at critical points of value creation.
Currently, KP Rx manages a portfolio of six companies and aims to address the lack of dedicated capital for healthcare commercialization in the region. The firm is strategically positioned to capitalize on undervalued early-stage opportunities with significant near-term upside potential, making it a key player in the Oceania healthcare investment landscape.
KP Rx invests primarily in private and early-stage public healthcare companies, specifically those at or after Series A funding. The firm emphasizes investments in biotech companies at Phase 2 and medical device companies that have received regulatory clearance. This targeted approach allows KP Rx to focus on high-potential companies that are poised for growth.
The investment strategy is designed to capitalize on the lack of dedicated capital for healthcare commercialization in Australia and New Zealand. KP Rx seeks undervalued early-stage opportunities that present significant near-term upside potential, ensuring that their investments align with critical points of value creation in the healthcare sector.
KP Rx's portfolio includes six notable companies that reflect its focus on healthcare innovation:
These companies exemplify KP Rx's commitment to investing in high-potential healthcare innovations that are at critical stages of development.
Hashan De Silva - Founder, Managing Partner. Hashan has extensive experience in healthcare investments and has led multiple successful funding rounds in the biotech sector.
Michael Slaven - COO. Michael brings operational expertise and has a background in managing healthcare startups, ensuring efficient operations within the firm.
Cameron Jones - CFO. Cameron has a strong financial background, having worked with various investment firms, and is responsible for overseeing the financial strategy of KP Rx.
Val Moingeon - Principal. Val has a background in healthcare innovation and plays a key role in identifying and evaluating potential investment opportunities.
Startups interested in pitching to KP Rx should send their proposals via email to info@kp-rx.com. It is important to include a comprehensive business plan and financial projections in the pitch deck. KP Rx typically reviews submissions promptly, so founders can expect a timely response.
Since its establishment in 2023, KP Rx has focused on building a portfolio of innovative healthcare companies. The firm has made significant strides in identifying high-potential investments in the biotech and medical device sectors.
As of now, there are no reported exits or additional fund raises, but KP Rx continues to actively seek new investment opportunities within its targeted sectors.
What are KP Rx's investment criteria?
KP Rx focuses on private and early-stage public healthcare companies, particularly those at or after Series A funding. The firm targets biotech companies at Phase 2 and medical device companies that have received regulatory clearance.
How can startups apply or pitch to KP Rx?
Startups can pitch to KP Rx by sending an email to info@kp-rx.com. It is advisable to include a detailed business plan and financial projections in the pitch.
What makes KP Rx different from other investors?
KP Rx specializes in addressing the lack of dedicated capital for healthcare commercialization in Australia and New Zealand, focusing on undervalued early-stage opportunities with significant growth potential.
What is the geographic scope of KP Rx's investments?
KP Rx primarily invests in Australia and New Zealand, targeting high-potential healthcare companies within these regions.
What type of post-investment involvement does KP Rx have?
KP Rx actively engages with its portfolio companies, providing operational support and strategic guidance to help them navigate the healthcare landscape.
What is the typical check size for KP Rx's investments?
While specific check sizes are not disclosed, KP Rx focuses on early-stage investments, typically aligning with Series A funding rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.